Bringing high-concentration biologics and larger injection volume product to the market requires more than a robust molecule. The interface of formulation and primary packaging plays a critical role in ensuring stability, quality, and performance of biologics. Join Coriolis Pharma and Stevanato Group experts to explore how an early and integrated strategy can reduce risk and drive drug product success.
The successful development of biologic drug products requires a holistic approach that extends beyond molecule design and formulation optimization. As biologics become increasingly complex, with high-concentration formulations and larger injection volumes gaining importance for patient-centric delivery, the interplay between drug product formulation and primary packaging becomes a critical factor influencing stability, quality, performance, and usability.
In this joint webinar, experts from Coriolis Pharma and Stevanato Group will discuss how formulation and packaging considerations can be integrated throughout biologics development to reduce risk and support robust drug product performance. Key topics will include approaches to develop stable high-concentration liquid formulations, manage viscosity, assess potential interactions between drug products and packaging materials, and apply complementary analytical methods to characterize formulation behavior and particles. Experts will also demonstrate how in silico assessments can be used to evaluate injection forces and delivery performance early in development, enabling more informed and efficient system selection.
Through real-world case studies, attendees will gain practical insights into how formulation and packaging decisions can impact product stability, manufacturability, delivery performance, and patient experience. The webinar will address fit-for-purpose container selection, injection-force and delivery-time considerations, and silicone-oil and particle risks. Application examples will illustrate how advanced syringe platforms can support sensitive biologics and high-viscosity formulations.
Join us to learn how early collaboration between formulation scientists and packaging experts can help address critical development challenges, improve product robustness, and accelerate the path from development to commercial success.
By ticking this box, you agree to the privacy policies of Coriolis Pharma, Stevanato Group and Livestorm, consenting to receiving communications related to this topic and other products or services within their portfolio